GSA Capital Partners LLP Takes $730,000 Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Key Points

• GSA Capital Partners LLP has acquired a new stake in Acadia Healthcare, purchasing 24,087 shares valued at approximately $730,000 during the first quarter.
• Analysts have a consensus rating of "Moderate Buy" for Acadia Healthcare, with a target price averaging $47.94, although some brokerages have adjusted their price targets downwards.
• Acadia Healthcare reported a quarterly earnings per share of $0.40, exceeding analysts' expectations, with a year-over-year revenue increase of 0.3% amounting to $770.51 million.

GSA Capital Partners LLP acquired a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 24,087 shares of the company's stock, valued at approximately $730,000.

Several other hedge funds have also recently made changes to their positions in ACHC. Quadrant Capital Group LLC increased its holdings in Acadia Healthcare by 287.1% during the fourth quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock valued at $50,000 after buying an additional 933 shares during the last quarter. UMB Bank n.a. increased its holdings in Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after buying an additional 755 shares during the last quarter. State of Wyoming purchased a new stake in Acadia Healthcare during the fourth quarter valued at approximately $56,000. Covestor Ltd increased its stake in shares of Acadia Healthcare by 27.2% in the fourth quarter. Covestor Ltd now owns 1,450 shares of the company's stock worth $58,000 after purchasing an additional 310 shares in the last quarter. Finally, Aquatic Capital Management LLC purchased a new stake in shares of Acadia Healthcare in the fourth quarter worth $97,000.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on ACHC. Guggenheim began coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price objective for the company. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Sunday. Stephens raised shares of Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Mizuho reduced their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research note on Wednesday, May 14th. Finally, Barclays reduced their price objective on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research note on Wednesday, May 14th. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, Acadia Healthcare has a consensus rating of "Moderate Buy" and an average target price of $47.94.

Acadia Healthcare Stock Performance

ACHC opened at $21.09 on Friday. The stock has a market capitalization of $1.94 billion, a price-to-earnings ratio of 10.39, a PEG ratio of 4.02 and a beta of 0.88. The company has a fifty day moving average of $22.49 and a 200 day moving average of $28.59. Acadia Healthcare Company, Inc. has a fifty-two week low of $20.35 and a fifty-two week high of $82.40. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.35 and a current ratio of 1.35.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. The business had revenue of $770.51 million during the quarter, compared to analysts' expectations of $769.90 million. During the same period last year, the company posted $0.84 EPS. The business's revenue was up .3% on a year-over-year basis. As a group, sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.